News
4d
News-Medical.Net on MSNNext-gen sequencing reveals the regulatory potential of the non-coding genome
The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a ...
SANTA CRUZ, CALIFORNIA, USA, March 4, 2024 / EINPresswire.com / -- RealSeq offers comprehensive next-generation sequencing (NGS) workflows to advance transcriptomics, large-scale RNA sequencing ...
The internalized GTC testing menu includes tissue and bone marrow-based DNA and RNA next generation sequencing of hematologic neoplasms and solid tumors.
Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving the way for better treatments for autoimmune diseases and cancer immunotherapy.
Together, these advances represent a pivotal development in delivering clinical-grade RNA imaging performance with seamless, high-throughput usability. Next-Generation HiFi Chemistry Unlocks Small ...
Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot ...
This webcast will introduce Next-Gen Protein Sequencing (NGPS) on Platinum Pro and illustrate how NGPS is complementary to traditional protein detection methods, enables detection of subtle ...
NGS technology, which allows for rapid and cost-effective sequencing of DNA and RNA, underpins not only cancer research and drug development but also agricultural innovation and forensic science.
CHICAGO — The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo next-generation sequencing testing, according to study results ...
Integration of next-generation RNA sequencing-based MammaPrint and BluePrint analysis in clinical decision making: Performance evaluation in the first 1095 cases. This is an ASCO Meeting Abstract from ...
Factors impacting treatment with abemaciclib + endocrine therapy in high risk early-stage HR+/HER2- breast cancer patients. Integration of next-generation RNA sequencing-based MammaPrint and BluePrint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results